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Background. Lung cancer accounts for half of all deaths from cancer in Europe and has the highest incidence in Southern Europe.
*e current study aimed to cluster trend changes of lung cancer incidence in Europe via the growth mixture model.Methods. *e
dataset included incidence rates of female and male lung cancer per 100,000 for 42 European countries during 1990–2016
compiled from the Gapminder database.*e growth mixture model was implemented to recognize different longitudinal patterns
and estimate the linear trend of each pattern in Mplus 7.4 software. Results. *e observed overall trend of incidence for female and
male lung cancer was raising and falling, respectively, and Iceland was the only country with higher incidence of female versus
male lung cancer in 2016. *e growth mixture model suggests 3 main patterns for the trend of lung cancer incidence both for
males and females. In male lung cancer, a sharp decreasing pattern was detected for 6 countries including Belarus, Estonia, Russia,
Slovenia, Ukraine, and the United Kingdom; also, a moderately decreasing pattern was observed among the other countries. In
female lung cancer, a moderate increasing trend was observed for 8 countries including the United Kingdom, Denmark, Hungary,
Iceland, Ireland, Montenegro, Netherlands, and Norway; the other patterns were categorized into two clusters with slow in-
creasing trends. Conclusion. Given the raising patterns in the incidence of lung cancer among European females, especially in the
United Kingdom, Denmark, Hungary, Iceland, Ireland, Montenegro, Netherlands, and Norway, urgent effective measures are
recommended to be taken.
1. Introduction
Lung cancer is now recognized as the most common male
cancer in the Asian continent and has the highest incidence
in South Europe and North America [1]. It also accounts for
half of all deaths from cancer in Europe and is the second
leading cause of cancer deaths among females [2, 3]. With
513,000 cases and 8.5% of all cancers, lung cancer accounts
for fourteen most common cancer with a higher prevalence
among males. In the Central and Eastern Europe, Hungary
with 109, Macedonia with 102, Serbia with 99, and the
Netherlands with 90 new cases per 100,000 annually had the
highest incidence, and Finland with 45 and Sweden with 29
new cases per 100,000 annually had the lowest incidence
rates of male lung cancer. Besides, Albania, Belarus, Bosnia
and Herzegovina, Bulgaria, Greece, Hungary, Montenegro,
the Netherlands, Romania, Serbia, and Ukraine, lung cancer
have been the leading cause of new deaths among men [4].
Previous studies showed that the incidence of lung
cancer in Hungary decreased by 1.3% from 1970 to 2005 in
men and increased by 1.3% in women. In the same region
(Eastern Europe), Romania has the highest increase with a
growth rate of 1.5%. In northern Europe, the rate of lung
cancer in men decreased by 2.5% between 1970 and 2007,
and in England, it increased by 1% in women. South Eu-
ropean women had one of the highest growth rates of lung
cancer with a 3% increase in Spain and Slovenia. In the
western European, during 1970–2007, France had a 0.9%
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reduction in lung cancer among men and a 4.2% increase in
cancer among women. Germany also had a 2.3% increase in
the rate of female lung cancer, but the highest rate of growth
was in the Netherlands, which had a 4.6% increase in cancer
rates among women [5]. Italy showed a 1.8% reduction in
lung cancer among men and a 1.2% increase in women [5];
in Montenegro, an increase of 3.9% between the years 1990
and 2004 and a decrease of 1.95% between 2015 and 2015 was
detected [6].
Growth mixture models (GMM) are known as capable
statistical methods to identify and cluster different lon-
gitudinal patterns which have been more attentive re-
cently. In GMM, diverse subgroups of trajectories can be
modeled easily as a hidden variable which should be es-
timated [7]. To the best of our knowledge, there was no
related previous study about modeling growth of lung
cancer incidence through Europe during the last decades.
*erefore, the current study aimed to cluster the trend
changes of lung cancer incidence in Europe via the growth
mixture model.
2. Materials and Methods
In this study, our dataset included the incidence rates of
female and male lung cancer per 100,000 for 42 European
countries during 1990–2016 compiled from the Gapminder
database that is freely available at http://www.gapminder.
org/data. *e growth mixture model was implemented to
recognize different longitudinal patterns and estimate linear
trend of each pattern. In the statistical modeling, the main
outcome was the annual incidence of lung cancer for males
or females at each country.
Using growth mixture models to cluster trajectories in
cancer epidemiology have been more attentive in the last
decades. In the study of Borumandnia et al., GMM was used
to find the main patterns of mortality among Iranian men
and women due to various cancers [8]. Salari et al. suggest
GMM to cluster trends in the liver cancer mortality in Asia
from 1990 to 2015, and Zayeri et al. performed GMM to
determine the new clusters of colon and rectum cancer
mortality in Asia and North Africa region [9, 10]. In the
current study, the growth mixture model with different
number of clusters (patterns) was fitted, and the most ap-
propriate model was estimated based on the P value of the
likelihood ratio test (LRT) in Mplus 7.4 software.
3. Results
Longitudinal trajectories of lung cancer in 42 European
countries for both males and females were monitored during
1990–2016. Romania and Netherlands had experienced the
highest increase in the incidence of male and female lung
cancer, respectively. Also, Finland and Ukraine showed the
highest decrease in the incidence of male and female lung
cancer, respectively, during the period of the study. Iceland
was the only country with higher incidence of female versus
male lung cancer in 2016 (Figures 1 and 2). Also, the trend
changes of tobacco smoking prevalence for all of the 42
European countries are shown in Figure 3. *e observed
trajectories were upward for Croatia and Moldova but
downward for the other countries.
Although the observed overall trend of the incidence for
female and male lung cancer was raising and falling, re-
spectively, we implemented the growth mixture model to
identify different trajectories. *e growth mixture model
with 3 clusters was chosen as the most appropriate for both
male and female lung cancer modeling based on the LRT test
(Tables 1 and 2). Also, related information about each
recognized pattern including the number of countries, in-
cidence rate in 1990 (intercept), and annual trend change
(slope) of estimated linear trend is summarized in Table 3.
For male lung cancer, 8 countries including Andorra,
Croatia, Hungary, Lithuania, Norway, Slovak Republic,
Spain, and Turkey belonged to cluster 1. Annual slope of
−0.66 per 100,000 showed a moderate decrease in these
countries. In the second cluster, slope of −1.5 per 100,000
indicated a sharp falling pattern for Belarus, Estonia, Russia,
Slovenia, Ukraine, and the United Kingdom countries, and
another 28 countries belonged to cluster 3 which had ex-
perienced an annual change of −0.56 per 100,000 at male
lung cancer (Figure 4). Modeling trend changes of female
lung cancer assigned Bulgaria, Georgia, Latvia, Macedonia,
Malta, Portugal, and Romania countries to a cluster with
almost a constant or very slow increasing pattern of inci-
dence over the study period. *e second cluster including
the United Kingdom, Denmark, Hungary, Iceland, Ireland,
Montenegro, Netherlands, and Norway showed a moderate
increasing trend, and another 27 countries belonged to
cluster 3 with slow raising trends (Figure 5).
4. Discussion
Time trends of lung cancer showed falling and raising
patterns for males and females, respectively, among most of
the European countries. Our results suggest 3 main patterns
for the trend of lung cancer incidence both for males and
females. In male lung cancer, a sharp decreasing pattern was
detected for 6 countries including Belarus, Estonia, Russia,
Slovenia, Ukraine, and the United Kingdom and a mod-
erately decreasing pattern was observed among the other
countries. In female lung cancer, a moderately increasing
trend was observed for 8 countries including the United
Kingdom, Denmark, Hungary, Iceland, Ireland, Montene-
gro, Netherlands, and Norway; the other patterns were
categorized into two clusters with slow increasing trends.
As it was mentioned by Aareleid, the peak of male lung
cancer incidence in Estonia was observed at 1991 and de-
creased thereafter. As a justification, the authors have
mentioned that growing public awareness and stricter to-
bacco control have stimulated overall favorable changes in
men, but not yet in women. *ey also report an overall
increasing trend of lung cancer incidence among women
which may be due to a substantial increase of tobacco
smoking, particularly among women, after the Second
World War [11]. In line with our results, the lung cancer
incidence reports in Russia indicate an increasing incidence
rate among women and a decreasing pattern among men.
*e observed pattern for women is unfavorable because it
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shows a rising burden of smoking attributable disease in
females [12]. Peto et al. announced that in the UK, women
and older men who were still current smokers in 1990 were
more likely than those in 1950 to have been persistent
cigarette smokers throughout adult life and so had higher
lung cancer rates than the current smokers in 1950 [13].
A previous study about the incidence of lung cancer in
Hungary during 1970–2005 showed that the yearly increase
in the incidence of LC decreased, as the results of our study,
characterized by a public perception that smoking is a health
hazard, allowing the introduction of comprehensive tobacco
control legislation [14]. However, related studies showed
that in countries such as Hungary and Poland, the average
number of cigarettes smoked per person per day is higher
than any member country of the EU. High lung cancer rates
around the year 2000 may also be associated with higher
rates of cigarette smoking in the 1980s (and before) in some
EUCSs, particularly in the Baltic countries [15].
In Spain, the trend of lung cancer increased among
women, as we showed. Diverging trends in the prevalence of
smoking could explain the increase in the rate of lung
cancer-related mortality among Spanish women since the
early 1990s [16]. In the Portugal, as we found, the rate of lung
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Figure 1: Bar chart of male lung cancer incidence among European countries.
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1955 and 2005. *ese results place Portugal at the end of the
third stage of the smoking epidemic [17]. In Belgium, the
study of Van Hemelrijck et al. showed that lung cancer was
decreased and increased for men and women, respectively,
during 1954–1997. Both prevalence and consumption de-
clined for Belgian males. In contrast, female cigarette
consumption increased over time, while prevalence
remained rather stable (about 20%) during the early 1990s.
*e same results were also reported in Netherlands. Female
lung cancer in all age groups showed a significant annual
increase in lung cancer during 1950–2000, which was
consistent with our results [18].
Formal statistics in Switzerland approved that decrease
in male lung cancer mortality was 20% over the last decade
(from 42.9 to 34.3/100 000). In contrast, lung cancer mor-
tality in women has steadily increased by 38% between 1981
and 1991 and by 47% between 1991 and 2001 to reach 10.7/
100 000 at all ages and 18.3 at age 35–64, due to increased
prevalence of smoking in subsequent generations of Swiss
women [19]. Szczuka and Roszkowski-Śliż found that lung
cancer incidence and mortality rate in men has been on the
stable level, even with the tendency to decline in the last
decade in Poland. Incidence and mortality rates among
women have continued to increase although the trend of
increase has slowed in the last years, as we showed. Despite
some improvement of epidemiological situation in lung
cancer in Poland, it still remains the most common ma-
lignancy in men and is on the third position in the most
frequent cancers in woman [20]. Increasing trend of female
lung cancer in the period of 1988–1992 was reported in
Bulgaria by Hristova et al. [21]. Also, the study of Eilstein
et al. in France found that during 1978–2002, female lung
cancer mortality rate increased by 3.3% annually. For men, a
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Figure 2: Bar chart of female lung cancer incidence among European countries.
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Figure 3: *e trend changes of tobacco smoking prevalence in European countries.
Table 1: Fit indices to estimate the best model for clustering
European male lung cancer.
Fit indices
Number of cluster
1 2 3 4 5 6
AIC 5752 5751 5745 5752 5760 5757
BIC 5808 5815 5818 5834 5850 5856
SSBIC 5708 5699 5687 5687 5687 5678
LRT P value — 0.24 <0.001 0.55 0.53 0.36
Table 2: Fit indices to estimate the best model for clustering
European female lung cancer.
Fit indices
Number of cluster
1 2 3 4 5 6
AIC 3059 3034 3026 3029 3050 3053
BIC 3115 3098 3099 3111 3140 3152
SSBIC 3014 2982 2968 2963 2978 2973
LRT P value — 0.23 0.09 0.69 0.91 0.50
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declining trend. *eir results highlight the relevance of
pursuing public health measures in order to cope more
actively with tobacco smoking in the prevention strategy
against lung cancer, specifically among women [22].
Study of Levi et al. in Germany showed that lung cancer
rates in young women rose from 0.8 to 1.0/100,000 in the
early 1970s to 1.7–1.9 in the mid-1990s and levelled off
during the last decade [23]. Moreover, based on the study of
Yilmaz, the increase in the cancer incidence is much faster
in men than women in Turkey, further widening the gap
between the incidence among men and women. An in-
crease in tobacco consumption was paralleled some 20–30
years later by an increase in the incidence of lung cancer;
similarly, a decrease in consumption is followed by a de-
crease in incidence [24]. A meta-analysis study in Turkey
showed that the rate of LC in females increased
Table 3: Intercept and slope of the estimated linear trend for each cluster of the growth mixture model.
Gender Cluster Number of countries
Intercept Slope
Estimate SE Estimate SE
Male
1 8 81.66 11.95 −0.66 0.21
2 6 89.45 3.85 −1.50 0.13
3 28 69.31 4.06 −0.56 0.12
Female
1 7 7.02 0.47 0.15 0.02
2 8 21.10 3.23 0.62 0.13



























































Figure 4:*e overall mean (top) and estimated linear trend (bottom) formale lung cancer. Cluster 1, Andorra, Croatia, Hungary, Lithuania,
Norway, Slovak Republic, Spain, and Turkey. Cluster 2, Belarus, Estonia, Russia, Slovenia, Ukraine, and the United Kingdom. Cluster 3,
other European countries.
6 Journal of Environmental and Public Health
significantly in the last decade which may be due to in-
creasing prevalence of smoking in women. *e prevalence
of smoking in Turkey has increased during the past 3
decades. Cigarette consumption increased by 10% from
1970 to 1985; however, this consumption went up to 44% in
1988 with a smoking prevalence of 63% for males and 24%
for females. Additionally, it has been suggested that female
smokers are more susceptible to lung cancer than male
smokers. When compared to the period 1986–1995, the
ratio of males decreased from 93.3 to 91.8. However, the
mean age increased from 58.5 to 59.8 years in the period of
1996–2005 [25].
Divergent trends among countries highlight the other
possible risk factors such as racial disparities in nonadjacent
counties [26], exposure to particulate matter air pollution
[27], and exposure to second-hand smoke [28]. Moreover,
the previous studies confirm a significant inverse association
was found between low education and lung cancer risk in
men in Central Europe [28, 29]. Finally, the downward
trends of male lung cancer in European countries may be
due to substantial decrease in dangers occupational expo-
sures such as arsenic and asbestos during the last decades
[28, 30, 31].
To the best of our knowledge, a few numbers of studies
were devoted to assess the trend changes of lung cancer
incidence in Europe. *is study tries to apply a highly ad-
vanced model along with the most recent epidemiological
data about lung cancer but lack of statistical modeling
studies in this field and accurate descriptive statistics about
the incidence rates in a few number of less developed
countries caused limitations in comparing obtained findings
in this study.
5. Conclusion
Given the raising patterns in the incidence of lung cancer
among European females, especially in the United Kingdom,
Denmark, Hungary, Iceland, Ireland, Montenegro, Neth-


































































Figure 5: *e overall mean (top) and estimated linear trend (bottom) for female lung cancer. Cluster 1, Bulgaria, Georgia, Latvia,
Macedonia, Malta, Portugal, and Romania. Cluster 2, the United Kingdom, Denmark, Hungary, Iceland, Ireland, Montenegro, Netherlands,
and Norway. Cluster 3, other European countries.
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